Study to Evaluate Xtressé Gummy Supplement in Men With Androgenic Alopecia

Part of paid clinical trials in Maitland, Florida.

Sponsor
Restore Biologics Holdings, Inc. dba Xtressé
Study ID
NCT07637071
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Xtressé Hair Growth Gummies — OTHER
    The nutraceutical supplement is powered by proprietary X-3 BioActive Blend and contains plant based extracts and regenerative compounds not commonly found in existing hair supplements.

Study Details

The goal of this study is to determine how safe and effective it is to improve hair growth using an active gummy treatment in men with androgenic alopecia. The main aims of this trial are: 1. To confirm using photographic analysis, changes in the quality, volume, and thickness of hair. 2. To gauge patient satisfaction with hair changes and application process. 3. Monitor and report any adverse events associated with the daily intake of Xtressé Participants who qualify will complete 3 visits after voluntary consent has been given. Participants will be given a 90-day supply of the gummies at visits 1 and 2 to cover the 6-month study period. Photographs and scalp analysis will be performed at each visit to measure changes in hair volume, thickness, and growth.

Key Dates

Start date
Jun 22, 2026
Status verified
Jun 2026
Primary completion
Jan 31, 2027
Completion
Mar 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Xtressé Nutraceutical Supplement Active
    Xtressé Nutraceutical Supplement Participants will receive a 90 day supply of gummy supplement 2 times during the study. Participants will take supplement daily and notate usage in log.

Primary Outcome Measure

Within-subject increase in hair density assessed via Canfield HairMetrix® Phototrichogram Analysis [ Time Frame: From enrollment to the end of treatment at 6 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Advanced Dermatology & Cosmetic SurgeryMaitlandFlorida32751
Dr. Priya Pohani
Matt Leavitt, DO (PRINCIPAL_INVESTIGATOR)
Advanced Dermatology & Cosmetic SurgeryPort OrangeFlorida32127
Kiya Arbogast
386-322-8310
Charles Dunn, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Maitland, FL

Related Studies